Earnings History Data for Selecta Biosciences, Inc. (SELB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company which develops targeted immunotherapies and vaccines. Its product pipelineincludes gene therapy, food allergy, malaria; SEL-212, which is a therapeutic enzyme indicated for refractory gout; SEL-070, which is indicated for smoking cessation and relapse prevention; SEL-701, which is indicated for the treatment of human papillomavirus associated cancer and SEL-212 consists of SVP-Rapamycin co-administered with pegsiticase, its pegylated uricase. Selecta Biosciences, Inc. is based in Watertown, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
02-03-2023 PM 8:00 AM ET
(Mar 2)
SELB Selecta Biosciences, Inc. 250.97 -0.03 -0.04 -0.04 Selecta Biosciences GAAP EPS of $0.04 beats by $0.11, revenue of $16.79M beats by $5.11M
[3/2/2023 7:35 AM]
1.59 -0.01 
(-0.31%)
1.70 0.10 
(6.25%)
0.65 - 2.73 1,049,444 1,240,000 29,811
03-11-2022 PM 7:30 AM ET
(Nov 3)
SELB Selecta Biosciences, Inc. 253.50 -0.01 0.00 -0.16 Selecta Biosciences GAAP EPS of -$0.05 misses by $0.04, revenue of $20.71M misses by $4.5M
[11/3/2022 8:04 AM]
1.69 0.06 
(3.37%)
1.59 -0.04 
(-2.45%)
0.65 - 4.34 1,062,342 630,000 40,546
04-08-2022 PM 7:30 AM ET
(Aug 4)
SELB Selecta Biosciences, Inc. 250.49 0.06 -0.03 -0.04 Selecta Biosciences GAAP EPS of $0.06 beats by $0.14, revenue of $39.3M beats by $25.52M
[8/4/2022 7:37 AM]
1.88 0.23 
(13.94%)
3.92 -0.40 
(-9.26%)
0.65 - 4.70 3,484,227 1,260,000 51,552
05-05-2022 PM 8:00 AM ET
(May 5)
SELB Selecta Biosciences, Inc. 121.45 -0.07 -0.09 -0.22 Selecta Biosciences GAAP EPS of $0.08 beats by $0.19, revenue of $34M beats by $20.88M
[5/5/2022 7:41 AM]
0.8168 0.02 
(1.97%)
0.86 0.06 
(7.37%)
0.69 - 5.28 1,256,542 1,340,000 20,885
10-03-2022 PM 8:00 AM ET
(Mar 10)
SELB Selecta Biosciences, Inc. 184.31 -0.04 -0.06 -0.14 Selecta Biosciences GAAP EPS of $0.10 beats by $0.18, revenue of $29.9M beats by $12.32M
[3/10/2022 8:09 AM]
1.61 -0.12 
(0.00%)
2.02 0.27 
(15.42%)
1.61 - 5.28 400,381 1,091,691 6,334
09-11-2021 PM 8:00 AM ET
(Nov 9)
SELB Selecta Biosciences 453.00 -0.16 -0.07 0.00 Selecta Biosciences EPS misses by $0.09, beats on revenue
[11/9/2021 8:05 AM]
3.87 -0.09 
(-2.40%)
3.89 -0.07 
(-1.77%)
2.67 - 5.70 1,440,349 1,020,000 28,743
13-05-2021 PM 8:00 AM ET
(May 13)
SELB Selecta Biosciences, Inc. 352.03 -0.22 -0.12 -0.21 Selecta Biosciences EPS misses by $0.10, beats on revenue
[5/13/2021 8:04 AM]
2.93 -0.07 
(-2.33%)
2.93 0.0 
(0.00%)
1.47 - 5.70 1,196,239 1,750,000 7,883
11-03-2021 PM 7:30 AM ET
(Mar 11)
SELB Selecta Biosciences, Inc. 409.43 -0.14 -0.15 -0.28 Selecta Biosciences EPS misses by $0.02, beats on revenue
[3/11/2021 8:01 AM]
3.90 0.0 
(0.00%)
4.07 0.17 
(4.36%)
1.42 - 5.70 720,930 1,473,768 6,701
05-11-2020 PM 7:30 AM ET
(Nov 5)
SELB Selecta Biosciences, Inc. 336.43 -0.09 -0.12 -0.26 Selecta Biosciences EPS misses by $0.19
[11/5/2020 7:44 AM]
3.24 -0.06 
(-1.82%)
3.24 0.0 
(0.00%)
1.29 - 4.83 2,347,425 5,803,412 500
06-08-2020 PM 7:30 AM ET
(Aug 6)
SELB Selecta Biosciences, Inc. 230.97 -0.17 0.32 -0.37 Selecta Biosciences EPS misses by $0.27
[8/6/2020 7:37 AM]
2.51 -0.27 
(-9.71%)
2.52 -0.26 
(-9.35%)
1.28 - 4.83 975,092 993,412 166,168